
### [MONDO:0020035](http://purl.obolibrary.org/obo/MONDO_0020035)
**Label:** rare otorhinolaryngologic tumor

**Subclasses:** [MONDO:0008067](http://purl.obolibrary.org/obo/MONDO_0008067) (nasopharyngeal carcinoma, susceptibility to, 2), [MONDO:0015386](http://purl.obolibrary.org/obo/MONDO_0015386) (Epignathus (disease)), [MONDO:0015392](http://purl.obolibrary.org/obo/MONDO_0015392) (nasal glial heterotopia), [MONDO:0011775](http://purl.obolibrary.org/obo/MONDO_0011775) (nasopharyngeal carcinoma), [MONDO:0014902](http://purl.obolibrary.org/obo/MONDO_0014902) (nasopharyngeal carcinoma, susceptibility to, 3; NPCA3), [MONDO:0015391](http://purl.obolibrary.org/obo/MONDO_0015391) (nasopharyngeal teratoma), [MONDO:0015393](http://purl.obolibrary.org/obo/MONDO_0015393) (nasal ganglioglioma), [MONDO:0017340](http://purl.obolibrary.org/obo/MONDO_0017340) (juvenile nasopharyngeal angiofibroma (disease)), [MONDO:0015459](http://purl.obolibrary.org/obo/MONDO_0015459) (nasopharynx carcinoma), [MONDO:0015070](http://purl.obolibrary.org/obo/MONDO_0015070) (laryngeal neuroendocrine tumor), [MONDO:0015071](http://purl.obolibrary.org/obo/MONDO_0015071) (middle ear neuroendocrine tumor), 

**Corr. equiv. classes:** [Orphanet:141107](http://www.orpha.net/ORDO/Orphanet_141107), [OMIM:161550](http://purl.obolibrary.org/obo/OMIM_161550), [Orphanet:141112](http://www.orpha.net/ORDO/Orphanet_141112), [Orphanet:150](http://www.orpha.net/ORDO/Orphanet_150), [OMIM:607107](http://purl.obolibrary.org/obo/OMIM_607107), [Orphanet:141115](http://www.orpha.net/ORDO/Orphanet_141115), [OMIM:617075](http://purl.obolibrary.org/obo/OMIM_617075), [Orphanet:100083](http://www.orpha.net/ORDO/Orphanet_100083), [Orphanet:141077](http://www.orpha.net/ORDO/Orphanet_141077), [Orphanet:100084](http://www.orpha.net/ORDO/Orphanet_100084), [Orphanet:289596](http://www.orpha.net/ORDO/Orphanet_289596), 

**Class expressions from DL-Learner:**

- Thing 19.20%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 19.20%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000023](http://purl.obolibrary.org/obo/HP_0000023) (Inguinal hernia))) 16.48%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 16.46%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 16.43%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 16.43%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 16.43%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000021](http://purl.obolibrary.org/obo/HP_0000021) (Megacystis))) 16.43%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 16.43%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 16.43%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 16.43%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 16.43%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 16.43%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 16.43%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 14.52%


